58 completed, 2 withdrawn, 1 terminated. 38 Phase 3, 8 Phase 2, 4 Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 38 | Completed 38 |
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 4 | Completed 4 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Infections, Streptococcal: new trials by email Literature Review of Infections, Streptococcal trials Research Report on Infections, Streptococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (4-dose presentation), Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (1-dose presentation), DTPw-HBV/Hib - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 320 | 2015-06-11 | 2018-08-02 |
| Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine GBS Vaccine - Infections, Streptococcal, Streptococcal Infections | Phase 2 | Completed | GlaxoSmithKline | 1053 | 2014-11-20 | 2019-12-05 |
| Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. BAL fluid sampling, Nasopharyngeal swab sampling - Infections, Streptococcal | Not applicable | Completed | GlaxoSmithKline | 197 | 2013-09-23 | 2019-10-04 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection Synflorix™ - Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Completed | GlaxoSmithKline | 52 | 2013-06-18 | 2019-07-09 |
| Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama Data collection - Infections, Streptococcal | Completed | GlaxoSmithKline | 1330 | 2013-03-01 | 2015-12-07 | |
| Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey Tympanocenthesis and urine collection - Infections, Streptococcal | Withdrawn | GlaxoSmithKline | 2012-11-01 | 2015-04-13 | ||
| Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children Middle ear fluid and urine. - Infections, Streptococcal | Withdrawn | GlaxoSmithKline | 2012-10-01 | 2015-04-13 | ||
| Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ Synflorix (3-Dose), Synflorix (2-Dose), Synflorix (Single Dose) - Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Completed | GlaxoSmithKline | 457 | 2012-09-04 | 2021-03-02 |
| Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants Pneumococcal conjugate vaccine GSK2830929A, Pneumococcal conjugate vaccine GSK2830930A, Synflorix™ - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 953 | 2012-07-11 | 2019-07-16 |
| Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children Pneumococcal vaccine GSK2189242A, Placebo, Prevnar 13® - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 1806 | 2012-05-21 | 2019-12-27 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers Pneumococcal vaccine GSK2830930A, Synflorix™ - Infections, Streptococcal | Phase 1 | Completed | GlaxoSmithKline | 61 | 2011-12-12 | 2021-02-10 |
| To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries Data collection (Retrospective), Data collection (Prospective) - Infections, Streptococcal | Completed | GlaxoSmithKline | 2258 | 2011-06-01 | 2014-07-28 | |
| Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A GSK1024850A (Synflorix), Tritanrix-HepB/Hib, Polio Sabin - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 300 | 2011-06-01 | 2019-06-06 |
| Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam Synflorix™( GSK1024850A), Infanrix hexa™ - Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Completed | GlaxoSmithKline | 300 | 2011-02-17 | 2020-01-02 |
| Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants Pneumococcal vaccine GSK 2189242A (LD formulation 1), Pneumococcal vaccine GSK 2189242A (HD formulation 2), Synflorix™ - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 1320 | 2011-02-09 | 2019-06-19 |
| Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea Synflorix™ Data collection - Infections, Streptococcal | Completed | GlaxoSmithKline | 622 | 2010-12-01 | 2017-01-13 | |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment GSK1024850A (SynflorixTM), Infanrix hexa, Infanrix-IPV/Hib - Infections, Streptococcal | Phase 4 | Completed | GlaxoSmithKline | 850 | 2010-11-12 | 2019-05-10 |
| Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria Pneumococcal vaccine GSK1024850A, InfanrixTM - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 105 | 2010-10-04 | 2018-09-20 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants Pneumococcal vaccine GSK 2189242A (LD formulation 1), Pneumococcal vaccine GSK 2189242A (HD formulation 2), Synflorix - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 576 | 2010-09-27 | 2019-05-29 |
| Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose Pneumococcal vaccine GSK1024850A, Infanrix-IPV/Hib - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 238 | 2010-07-12 | 2018-09-20 |
Showing 20 of 61. Sign in to see all of them.
Streptococcal Infections (61) · Pneumococcal Infections (24) · Haemophilus Infections (11) · Pneumonia (8) · Otitis Media (6) · Fever (2) · Otitis (2) · Respiratory Tract Infections (2) · Acquired Immunodeficiency Syndrome (1) · Anemia, Sickle Cell (1) · Community-Acquired Pneumonia (1) · Meningitis (1) · Meningococcal Infections (1) · Premature Birth (1) · Toxemia (1)
Bacterial Infections (61) · Bacterial Infections and Mycoses (61) · Gram-Positive Bacterial Infections (61) · Infections (61) · Gram-Negative Bacterial Infections (12) · Pasteurellaceae Infections (11) · Lung Diseases (8) · Respiratory Tract Diseases (8) · Ear Diseases (7) · Otorhinolaryngologic Diseases (7) · Respiratory Tract Infections (6) · Otitis (5) · Body Temperature Changes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
PHiD-CV vaccine (18) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (15) · Heptavalent Pneumococcal Conjugate Vaccine (6) · Hepatitis A Vaccines (5) · Pneumococcal Vaccines (5) · 13-valent pneumococcal vaccine (4) · Hepatitis B Vaccines (3) · Hiberix (3) · RIX4414 vaccine (3) · Tritanrix-HepB vaccine (3) · 10-valent pneumococcal conjugate vaccine (2) · Acetaminophen (2) · Data Collection (2) · Pentetic Acid (2) · Blood Specimen Collection (1)
GlaxoSmithKline (61)
Poland (10) · Finland (7) · Germany (7) · Czechia (6) · Belgium (5) · Spain (5) · Sweden (5) · Philippines (3) · South Korea (3) · France (2) · Greece (2) · India (2) · Mali (2) · Mexico (2) · Nigeria (2)
PMID 25008901, PMID 25278086, PMID 34986178, PMID 19325447, PMID 19325451, PMID 19325452, PMID 23158882, PMID 24287186, PMID 24356787, PMID 24599529, PMID 24607003, PMID 25127244, PMID 26020101, PMID 26284652, PMID 27125273, PMID 27145999, PMID 27457584, PMID 28079828, PMID 28425818, PMID 29277353, PMID 29503110, PMID 30084702, PMID 30145098, PMID 31122856, PMID 32035706, PMID 32169390, PMID 33245004, PMID 41495936
2008 (3), 2005 (1), 2009 (1), 2015 (1)